{"title":"Evaluating saliva for SARS-CoV-2 detection: A practical alternative","authors":"Nusrat Sultana , Partha Protim Biswas , Tania Islam Resma , Nusrat Fatema , Rabeya Sharmin , Afroza Akbar Sweety , Amirul Huda Bhuiyan , Asish Kumar Ghosh , Sultana Shahana Banu","doi":"10.1016/j.diagmicrobio.2025.116902","DOIUrl":null,"url":null,"abstract":"<div><div>Accurate and rapid detection of SARS-CoV-2 is critical for controlling the spread of COVID-19, particularly among asymptomatic carriers. This study evaluates saliva as a viable alternative to nasopharyngeal swabs (NPS) for SARS-CoV-2 detection using real-time RT-PCR and rapid antigen testing (RAT). A total of 201 paired NPS and saliva samples were collected and analyzed. Saliva-based RT-PCR demonstrated 100 % (95 % CI, 94.64 % to 100 %) sensitivity and 97.10 % (95 % CI, 92.74 % to 99.2 %) specificity, with an overall accuracy of 98.05 % (95 % CI, 95.44 % to 99.47 %), closely aligning with NPS results. Similarly, saliva-based RAT exhibited comparable diagnostic performance to NPS-based RAT, with sensitivity and specificity of 100 % (95 % CI 90.51-100 %) and 99.39 % (95 % CI 96.67-99.98 %) respectively. When compared to the gold standard NPS real-time RT-PCR, the sensitivity of RAT using saliva and NPS samples was found to be 69.07 % (95 % CI, 58.88 % to 78.08 %) and 69.79 % (95 % CI, 59.57 % to 78.75 %), respectively. Notably, for cases with cycle threshold (Ct) values ≤30, saliva RAT achieved 97.30 % (95 % CI, 85.84 % to 99.93 %) sensitivity, highlighting its effectiveness in detecting infectious cases. Therefore, saliva offers a practical alternative to NPS for large-scale screening, particularly in resource-limited settings, due to its non-invasive nature, ease of self-collection, and high diagnostic accuracy</div></div>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"113 2","pages":"Article 116902"},"PeriodicalIF":2.1000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic microbiology and infectious disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0732889325002251","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Accurate and rapid detection of SARS-CoV-2 is critical for controlling the spread of COVID-19, particularly among asymptomatic carriers. This study evaluates saliva as a viable alternative to nasopharyngeal swabs (NPS) for SARS-CoV-2 detection using real-time RT-PCR and rapid antigen testing (RAT). A total of 201 paired NPS and saliva samples were collected and analyzed. Saliva-based RT-PCR demonstrated 100 % (95 % CI, 94.64 % to 100 %) sensitivity and 97.10 % (95 % CI, 92.74 % to 99.2 %) specificity, with an overall accuracy of 98.05 % (95 % CI, 95.44 % to 99.47 %), closely aligning with NPS results. Similarly, saliva-based RAT exhibited comparable diagnostic performance to NPS-based RAT, with sensitivity and specificity of 100 % (95 % CI 90.51-100 %) and 99.39 % (95 % CI 96.67-99.98 %) respectively. When compared to the gold standard NPS real-time RT-PCR, the sensitivity of RAT using saliva and NPS samples was found to be 69.07 % (95 % CI, 58.88 % to 78.08 %) and 69.79 % (95 % CI, 59.57 % to 78.75 %), respectively. Notably, for cases with cycle threshold (Ct) values ≤30, saliva RAT achieved 97.30 % (95 % CI, 85.84 % to 99.93 %) sensitivity, highlighting its effectiveness in detecting infectious cases. Therefore, saliva offers a practical alternative to NPS for large-scale screening, particularly in resource-limited settings, due to its non-invasive nature, ease of self-collection, and high diagnostic accuracy
期刊介绍:
Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.